Xuan Jin

No.8, Xishiku Street
Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Chinese consensus on first-line precision therapy for advanced gastric cancer.

Chinese consensus on first-line precision therapy for advanced gastric cancer.

Journal: Innovation (Cambridge (Mass.))

Published: September 16, 2025

Chemotherapy plus bevacizumab vs chemoimmunotherapy for metastatic colorectal cancer: Real-world analysis.

Chemotherapy plus bevacizumab vs chemoimmunotherapy for metastatic colorectal cancer: Real-world analysis.

Journal: World journal of gastrointestinal oncology

Published: May 28, 2025

Targeted therapy combined with immunotherapy vs trifluridine/tipiracil with bevacizumab as late-line therapy in metastatic colorectal cancer.

Targeted therapy combined with immunotherapy vs trifluridine/tipiracil with bevacizumab as late-line therapy in metastatic colorectal cancer.

Journal: World journal of gastroenterology

Published: May 26, 2025

Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report.

Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report.

Journal: World journal of gastrointestinal oncology

Published: April 28, 2025

Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer.

Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer.

Journal: World journal of gastroenterology

Published: April 10, 2025

Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer.

Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer.

Journal: Scientific reports

Published: March 18, 2025

Chemotherapy plus bevacizumab with or without anti-programmed death 1 immunotherapy as the second-line therapy in colorectal cancer.

Chemotherapy plus bevacizumab with or without anti-programmed death 1 immunotherapy as the second-line therapy in colorectal cancer.

Journal: World journal of gastroenterology

Published: March 11, 2025

Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report.

Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report.

Journal: Frontiers in oncology

Published: November 18, 2024

Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.

Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.

Journal: Cancer immunology, immunotherapy : CII

Published: May 20, 2024

Effect of perioperative chemotherapy on resection of isolated pulmonary metastases from colorectal cancer: A single center experience.

Effect of perioperative chemotherapy on resection of isolated pulmonary metastases from colorectal cancer: A single center experience.

Journal: World journal of gastrointestinal oncology

Published: May 11, 2024

Adjuvant chemotherapy for isolated resectable colorectal lung metastasis: A retrospective study using inverse probability treatment weighting propensity analysis.

Adjuvant chemotherapy for isolated resectable colorectal lung metastasis: A retrospective study using inverse probability treatment weighting propensity analysis.

Journal: World journal of gastrointestinal surgery

Published: May 11, 2024

Smell cancer by machine learning-assisted peptide/MXene bioelectronic array.

Smell cancer by machine learning-assisted peptide/MXene bioelectronic array.

Journal: Biosensors & bioelectronics

Published: April 10, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026